Brief: Seelos Therapeutics Receives Nasdaq Notice On Not Regained Compliance With Rule 5550(A)(2)
26/05/2023 21:35
May 26 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS INC - ON MAY 23, NASDAQ PROVIDED
NOTICE TO
CO THAT IT HAS NOT REGAINED COMPLIANCE WITH RULE 5550(A)(2)
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio